Last updated on November 2019

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Subjects With Active Ankylosing Spondylitis

Brief description of study

The purpose of the study is to demonstrate the efficacy, safety and tolerability of bimekizumab administered subcutaneously (sc) compared to placebo in the treatment of subjects with active ankylosing spondylitis (AS).

Clinical Study Identifier: NCT03928743

Find a site near you

Start Over

As0011 20038

Nankoku, Japan
  Connect »